Skip to main content
Default Image

Removing the Profit From Our Pills: The Case for a Public Pharma System

Any American who has paid the price of a patent-protected medicine knows the core flaw in the U.S. prescription drug system: our elected leaders have handed over control to profit-hungry corporations. And for-profit corporations gonna for-profit, as the kids would say. That is especially true when the corporations are gifted with long-term monopolies on life-essential medicines, which gives them the leverage to set take-it-or-leave it prices that net billions in revenue extracted from all of us. It doesn’t have to be this way. That is the message of an exciting new report, “Medicine for All: The Case for a Public Option in the Pharmaceutical Industry,” by Dana Brown, director of the Next System Project of the organization Democracy Collaborative

Publication date: 2019-09-17
Parent publication: Common Dreams
Publication URL: https://www.commondreams.org/views/2019/09/18/removing-profit-our-pills-case-public-pharma-system

More related work

Default Image

Healthcare as a public service: Redesigning U.S. healthcare with health and equity at the center

The Veterans Health Administration—the country’s only fully public, integrated healthcare system—has a lot to tell us about how a national healthcare service for the United States might operate.

read more
Default Image

Preston is putting socialist policies into practice

Labor movements must pursue a social and economic vision that can address the deep structural inequalities these pandemic years have exposed. Preston gives a glimpse of the exciting possibilities that collaboration with unions could achieve.

read more
Default Image

This must be the year of climate action—we've wasted so many

The climate issue has grown too large and devastating to ignore. We need the demand for action raised to the highest decibel our civil society can generate.

read more